Healthcare Reform Passes House, Has Implications for Pharma, CME

The healthcare reform bill that passed the House on March 21 with a 219-212 majority aims to change not only healthcare delivery in the United States, but also the reporting requirements for payments between pharmaceutical and medical-device companies and physicians. Included in the healthcare reform bill, called the Patient Protection and Affordable Care Act, are Physician Payment Sunshine Provisions that would affect both